Pin to quick picksMotif Bio Share News (MTFB)

Share Price Information for Motif Bio (MTFB)

London Stock Exchange
Share Price: 2.30
Bid: 2.21
Ask: 2.39
Change: -0.07 (-2.95%)
Spread: 0.18 (8.14%)
Open: 2.37
High: 2.390
Low: 2.274
Yest. Close: 2.37
MTFB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Motif Bio Postpones Next Amortisation Date Of Hercules Loan Facility

(Alliance News) - Biopharmaceutical firm Motif Bio PLC said on Thursday has amended its loan agreement with Hercules Capital Inc, delaying the next amortisation date by one month to September a to

1 Aug 19 11:43

Amphion Innovations To Work With Debt Providers To Refinance Facility

(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the in at

12 Jun 19 18:16

WINNERS & LOSERS SUMMARY: Rolls Royce And L&G Rise On Pension Pact

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - WINNERS----------Rolls up

6 Jun 19 10:47

Motif Bio Shareholders Reject Remuneration Report Resolution

LONDON (Alliance News) - Motif Bio PLC on Friday said that shareholders voted against approval of the company's remuneration report.At the clinical-stage biopharmaceutical firm's on

31 May 19 15:32

Motif Bio to work with Lamellar on cystic fibrosis treatment possibility

(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with Lamellar Biomedical, under which Motif Bio would conduct an in vivo preclinical study evaluating iclaprim in combination with Lamellar's patented 'Lamellasome' technology.

1 May 19 10:46

Motif Bio Shares Up On Agreement With Lamellar To Start Clinical Study

LONDON (Alliance News) - Shares rose in Motif Bio PLC on Wednesday as it signed an agreement with Lamellar Biomedical to study the combination of Motif's iclaprim with Lamellar's in the at

1 May 19 09:26

Motif Bio Appoints Andrew Powell As Non-Executive Director

LONDON (Alliance News) - Motif Bio PLC, a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, said Friday it has appointed Andrew Powell as non-executive has as

26 Apr 19 14:09

Motif Bio 2018 Loss Narrows As Research Costs Fall Despite US Delay

LONDON (Alliance News) - Motif Bio PLC said Monday its 2018 loss narrowed significantly as research costs fell, despite an unexpected delay in its new drug application in the US.In 2018, to

15 Apr 19 10:50

Amphion Innovations Pledges Polarean Shares As Extra Security For Loan (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has pledged its holding in Polarean Imaging PLC as additional security against its loan facility with its debt in Amphion closed 22%

1 Apr 19 16:48

WINNERS & LOSERS SUMMARY: Inmarsat Up As Private Equity Firms Make Bid

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Wednesday.----------FTSE 100 - Group, up 1.1%. The telecommunications was

20 Mar 19 10:31

Amphion Innovations Sells More Shares In Motif Bio As Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Tuesday said it sold 3.3 million shares in its Motif Bio PLC partner company as a partial loan repayment.Amphion Innovations develops and

19 Mar 19 16:20

Motif Bio Chair Morgan Stands Down, Williams Becomes Interim Chair

LONDON (Alliance News) - Motif Bio PLC said Monday Chair Richard Morgan had resigned from the biopharmaceutical firm, to be replaced by biopharma veteran Bruce Williams as interim - who also as of

18 Mar 19 11:46

Amphion Innovations Sells Partner's Motif Bio Shares In Loan Repayment (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC on Friday said it sold 1.8 million shares in partner pharmaceutical company Motif Bio PLC to repay a loan facility.Amphion made USD144,000

15 Mar 19 09:26

Amphion Innovations Agrees To Amend 2014 Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said Monday it has amended its loan facility first agreed in 2014 and then amended last October.Amphion amended the loan interest rate to to

11 Mar 19 18:11

WINNERS & LOSERS SUMMARY: Reckitt Rises After Strong Annual Results

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------Reckitt its

18 Feb 19 10:43

Login to your account

Don't have an account? Click here to register.